Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
The post Cancer drug with accelerated approval fails Phase III trial appeared first on European Pharmaceutical Review.
Original Article: Cancer drug with accelerated approval fails Phase III trial